首页> 美国卫生研究院文献>Medicina >Prevalence of Diabetic Retinopathy in Type 1 and Type 2 Diabetes Mellitus Patients in North-East Poland
【2h】

Prevalence of Diabetic Retinopathy in Type 1 and Type 2 Diabetes Mellitus Patients in North-East Poland

机译:波兰东北波兰1型和2型糖尿病患者的糖尿病性视网膜病变患病率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

: The global epidemic of diabetes, especially type 2 (DM2), is related to lifestyle changes, obesity, and the process of population aging. Diabetic retinopathy (DR) is the most serious complication of the eye caused by diabetes. The aim of this research was to assess the prevalence of diabetic retinopathy in type 1 and type 2 diabetes mellitus patients in north-east Poland. : The eye fundus was assessed on the basis of two-field 50 degrees color fundus photographs that showed the optic nerve and macula in the center after the pupil was dilated with 1% tropicamide. : The experimental group included 315 (26%) patients with type 1 diabetes mellitus (DM1) and 894 (74%) patients with DM2. DM1 patients were diagnosed with DR in 32.58% of cases, with non-proliferative diabetic retinopathy (NPDR) in 24.44% of cases, proliferative diabetic retinopathy (PDR) in 1.59% of cases, diabetic macular edema (DME) in 5.40% of cases, and PDR with DME in 0.95% of cases. DR was found in DM2 patients in 23.04% of cases, NPDR in 17.11% of cases, PDR in 1.01% of cases, DME in 4.81% of cases, and PDR with DME in 0.11% of cases. The presented study is the first Polish study on the prevalence of diabetic retinopathy presenting a large group of patients, and its results could be extrapolated to the whole country. Diabetic retinopathy was found in 25.48% of patients in the whole experimental group. The above results place Poland within the European average, indicating the quality of diabetic care offered in Poland, based on the number of observed complications.
机译::全球糖尿病特别是2型糖尿病(DM2)的流行与生活方式的改变,肥胖症和人口老龄化过程有关。糖尿病性视网膜病(DR)是糖尿病引起的最严重的眼部并发症。这项研究的目的是评估波兰东北部1型和2型糖尿病患者的糖尿病视网膜病变患病率。 :根据两场50度彩色眼底照片对眼底进行评估,该照片显示了在用1%托吡卡胺扩大瞳孔后中央的视神经和黄斑。 :实验组包括315名(26%)1型糖尿病(DM1)患者和894名(74%)DM2患者。 DM1患者被诊断患有DR的比例为32.58%,非增生性糖尿病视网膜病变(NPDR)的比例为24.44%,增生性糖尿病视网膜病变(PDR)的比例为1.59%,糖尿病性黄斑水肿(DME)的比例为5.40% ,以及使用DME的PDR(占0.95%的情况)。在DM2患者中发现DR的比例为23.04%,NPDR为17.11%,PDR的比例为1.01%,DME的比例为4.81%,DDR和DME的比例为0.11%。这项研究是波兰针对糖尿病性视网膜病患病率进行的第一项波兰研究,该研究涉及大量患者,其研究结果可以推广到全国。在整个实验组中,发现糖尿病性视网膜病的比例为25.48%。上述结果将波兰置于欧洲平均水平之内,表明根据观察到的并发症的数量,波兰提供的糖尿病护理的质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号